4//SEC Filing
Fox Christine 4
Accession 0000950170-24-026063
CIK 0000818686other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:35 PM ET
Size
5.9 KB
Accession
0000950170-24-026063
Insider Transaction Report
Form 4
Fox Christine
EVP, Head of U.S. Commercial
Transactions
- Award
Restricted Share Units
2024-03-04+81,845→ 81,845 total→ Ordinary Shares (81,845 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on March 4, 2024, with 20,461 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001998173
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:35 PM ET
- Size
- 5.9 KB